oxonic acid has been researched along with Gastric Ulcer in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silva, CR | 1 |
Fröhlich, JK | 1 |
Oliveira, SM | 1 |
Cabreira, TN | 1 |
Rossato, MF | 1 |
Trevisan, G | 1 |
Froeder, AL | 1 |
Bochi, GV | 1 |
Moresco, RN | 1 |
Athayde, ML | 1 |
Ferreira, J | 1 |
Iwasaki, Y | 1 |
Sasako, M | 1 |
Yamamoto, S | 1 |
Nakamura, K | 1 |
Sano, T | 1 |
Katai, H | 1 |
Tsujinaka, T | 1 |
Nashimoto, A | 1 |
Fukushima, N | 1 |
Tsuburaya, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Apatinib Plus XELOX Regime as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Patients With Lymph Node Metastasis[NCT03229096] | Phase 2 | 35 participants (Anticipated) | Interventional | 2017-02-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for oxonic acid and Gastric Ulcer
Article | Year |
---|---|
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2013 |
1 other study available for oxonic acid and Gastric Ulcer
Article | Year |
---|---|
The antinociceptive and anti-inflammatory effects of the crude extract of Jatropha isabellei in a rat gout model.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Arthritis, Gouty; Biomarkers, Pharmacological; Disease | 2013 |